Cancer Genetics, Nikon Ink Italian Distribution Deal for DNA-FISH Probes | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer Genetics today said that it and Nikon's Italian subsidiaries have entered into a distribution agreement covering Cancer Genetics' DNA probes intended for fluorescent in situ hybridization.

The deal between Cancer Genetics Italia and Nikon Instruments SpA is also anticipated to expand into other countries in Western Europe, where more than 350,000 FISH-based diagnostic tests are performed annually, Rutherford, NJ-based Cancer Genetics said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.